Clinical trials are studies that evaluate the effectiveness of new drugs or treatment strategies. Future progress in the treatment of myeloproliferative neoplasms (MPNs) will result from the continued evaluation of new treatments in clinical trials. Patients who are interested in participating in a clinical trial should discuss the risks and benefits of clinical trials with their physician. Check out MPN clinical trial highlights for summer 2015 provided by the MPN Research Foundation here.
For more of the latest information on MPNs, visit the MPN Information Center.
LEARN MORE ABOUT PV
- Sign up for the monthly MPN newsletter here.
- Join the CancerConnect online support group to join ongoing discussions with other individuals affected by MPNs here.
- Follow CancerConnect on Facebook and Twitter.
Copyright © 2018 CancerConnect. All Rights Reserved.